1
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signalling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li
C, Wang J, Chen E and Quan Z: Long non-coding RNA LINC00152
promotes gallbladder cancer metastasis and epithelial-mesenchymal
transition by regulating HIF-1α via miR-138. Open Biol.
7:1602472017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu L, Zhao X, Zou H, Bai R, Yang K and
Tian Z: Hypoxia promotes gastric cancer malignancy partly through
the HIF-1α dependent transcriptional activation of the long
Non-coding RNA GAPLINC. Front Physiol. 7:4202016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pirola CJ, Fernández Gianotti T, Castaño
GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M,
Flichman D, Mirshahi F, Sanyal AJ and Sookoian S: Circulating
microRNA signature in non-alcoholic fatty liver disease: From serum
non-coding RNAs to liver histology and disease pathogenesis. Gut.
64:800–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhu KP, Zhang CL, Shen GQ and Zhu ZS: Long
noncoding RNA expression profiles of the doxorubicin-resistant
human osteosarcoma cell line MG63/DXR and its parental cell line
MG63 as ascertained by microarray analysis. Int J Clin Exp Pathol.
8:8754–8773. 2015.PubMed/NCBI
|
17
|
Li JP, Liu LH, Li J, Chen Y, Jiang XW,
Ouyang YR, Liu YQ, Zhong H, Li H and Xiao T: Microarray expression
profile of long noncoding RNAs in human osteosarcoma. Biochem
Biophys Res Commun. 433:200–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li W, Xie P and Ruan WH: Overexpression of
lncRNA UCA1 promotes osteosarcoma progression and correlates with
poor prognosis. J Bone Oncol. 5:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Sun XH, Yang LB, Geng XL, Wang R and Zhang
ZC: Increased expression of lncRNA HULC indicates a poor prognosis
and promotes cell metastasis in osteosarcoma. Int J Clin Exp
Pathol. 8:2994–3000. 2015.PubMed/NCBI
|